Tauriga Sciences Inc. Commences the
Largest Tauri-Gum Production Run in Company History in Response to
Substantially Improved Macro-Industry Outlook
The Tauri-Gum™ Product Line has
Increased its Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Infusion
Concentrations to 20mg per Each Piece of Chewing Gum
NEW YORK, NY -- February 10, 2021 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating, diversified
life sciences company, with a proprietary line of CBD & CBG
infused Supplement chewing gums (Flavors: Pomegranate, Blood
Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as
an ongoing Pharmaceutical Development initiative, today announced
that it has commenced the largest Tauri-Gum™ production run in
Company history, in response to substantially improved
macro-industry outlook. Additionally, the Company continues
to experience increasingly strong levels of interest – from a broad
array of prospective retail & wholesale customers.
When completed, this above-referenced production run will
yield Tauri-Gum™ product inventory – worth in terms of retail value
– well in excess of $1,000,000 USD.
There has also been an important formulation modification,
applicable to this production run. The Company has made the
strategic decision to increase the CBD and CBG infusion
concentrations to 20mg per each piece of chewing gum.
Accordingly – Mint, Blood Orange, Pomegranate Tauri-Gum™ flavors
(20mg CBD / each piece of chewing gum) and Peach-Lemon, Black
Currant Tauri-Gum™ flavors (20mg CBG / each piece of chewing
gum). The Packaging will also be updated to reflect all of
the certifications (i.e. Kosher, Halal) and compliance features
(i.e. QR codes, UPCs).
Moving forward, the Company is confident about its growth
prospects for the remainder of Calendar Year 2021. The
Company’s highest margin E-Commerce business segment continues to
show overall strength and there has been an acceleration in online
customer acquisition. Lastly, the Company has worked with
great diligence to enhance its existing infrastructure and increase
its production capacity – to strengthen its ability to meet
potential increases in demand.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and
initiatives. The company manufactures and distributes
several proprietary retail products and product lines, mainly
focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles
market segment. The main product line, branded as
Tauri-Gum™, consists of a proprietary supplement chewing gum that
is Kosher certified, Halal certified, and Vegan Formulated (CBD
Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG
Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) &
(Vitamin C + Zinc “Immune Booster” Flavor: Pear
Bellini). The Company’s commercialization strategy
consists of a broad array of retail customers, distributors, and a
fast-growing E-Commerce business segment (E-Commerce
website: www.taurigum.com). Please visit our corporate
website, for additional information, as well as inquiries,
at http://www.tauriga.com
Complementary to the Company’s retail business, is its ongoing
Pharmaceutical Development initiative. This relates to the
development of a proposed Pharmaceutical grade version of
Tauri-Gum™, for nausea regulation (specifically designed for the
following indication: Patients Subjected to Ongoing Chemotherapy
Treatment). On March 18, 2020, the Company announced that it had
filed a provisional U.S. patent application covering its
pharmaceutical grade version of Tauri-Gum™. The Patent, filed
with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS
OF MANUFACTURING, AND METHODS OF TREATMENT”. On December 18,
2020 the Company disclosed that it had entered into a Master
Services Agreement with CSTI to lead the Company's clinical
development efforts.
On October 6, 2020, the Company announced that it has been
approved to operate as a U.S. Government Vendor (CAGE CODE #
8QXV4).
The Company is headquartered in Wappingers Falls, New
York. In addition, the Company operates a full time
E-Commerce fulfillment center located in LaGrangeville, New
York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
Contact:
Tauriga Sciences, Inc.
4 Nancy Court, Suite 4
Wappingers Falls, NY 12590
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Company Instagram: @taurigum
Personal Instagram: @sethsms47
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2024 to May 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From May 2023 to May 2024